Obesity-drug developer BioAge Labs Inc. gained about 20% after its initial public offering on Thursday, while natural-gas ...

Still, investor preference for companies with a clear path to profitability has kept enthusiasm in check, with analysts ...

BKV shares rose by 3.1% on their New York Stock Exchange debut on Thursday. This gives the U.S. Natural Gas Producer a market cap of $1.56 Billion.

As the company is focused on developing treatments for autoimmune diseases, it is also developing MAU868, a monoclonal ...

(Reuters) - Shares of BKV rose 3.1% in their debut on the New York Stock Exchange on Thursday, giving the U.S. natural gas ...

Japanese conglomerate Mitsubishi will acquire a 10% stake in a Sarawak natural gas liquefaction facility run by Malaysian state energy firm Petroliam Nasional for a ten-year period by the end of 2024, ...

Texas-based Barnett Shale driller BKV Inc. priced below the estimated range, while obesity-drug developer BioAge Labs Inc. priced midrange ahead of their first day of trading on Thursday. As the ...

Texas-based Barnett Shale driller prices below the estimated range, while obesity-drug developer BioAge prices midrange ahead ...

BKV Corporation (“BKV”) today announced the pricing of its initial public offering of 15,000,000 shares of its common stock at $18.00 per share. The underwriters will have a 30-day option to purchase ...

Natural gas producer BKV Corp said on Wednesday it had raised $270 million in its U.S. initial public offering.

BioAge Labs (BIOA), which is developing a drug to augment popular weight-loss medications such as Wegovy and Zepbound, has upsized its proposed IPO. Read more here.